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Summary
Purpose of study: To report the epidemiological, clinical, therapeutic and evolutionary aspects
of rhinoscleroma in ENT departments of university hospitals (Côte d’Ivoire).
Material and method: Retrospective study of rhinoscleroma conducted in the ENT and head
and neck surgery departments in Côte d’Ivoire from January 1980 to December 2008 including
the cases of conﬁrmed rhinoscleroma and the treated cases.
Results: Fourteen cases of rhinoscleroma were found in 28 years. The early manifestations
were not speciﬁc enough so the patients were seen with clinical status with obvious disorders
or physical discomfort. Treatment was medical and surgical. Medical therapy was based on
streptomycin, thiopenicol or ciproﬂoxacin administration. Surgery consisted in removing the
ﬁbrous adhesions to correct the functional and aesthetic disorders.
Conclusion: Rhinoscleroma has become a more and more rare disease because of the sen-
sitivity to the new molecules. Diagnosis can be difﬁcult and delayed because of its clinical
polymorphism.
© 2010 Elsevier Masson SAS. All rights reserved.
∗ Corresponding author. Tel.: +00 225 07 85 99 55;
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doi:10.1016/j.anorl.2010.10.006ntroductioncleroma or rhinoscleroma is a chronic pathology of the
espiratory tract caused by Klebsiella rhinoscleromatis. It
ost commonly affects the nasal cavity in more than 95%
f the cases [1—2] (hence the term of rhinoscleroma). It is
served.
8Table 1 Distribution of patients according to the year.
Number of patients Percentage %
1980 — 1989 9 64.3
1990 — 2000 3 21.4
2001 — 2008 2 14.3
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Medical treatment was based on the association of antibi-
otics and corticoids: streptomycin (10 cases) in patients
showing no inner ear impairment with regular follow-up
through pure-tone audiometry until the stabilization ofTotal amount 14 100
64.3% of the patients were seen between 1980 and 1990.
haracterized by a speciﬁc spreading granulomapous condi-
ion with pseudotumoral process then ﬁbrosis evolution. The
esult is a progressive obstruction of the respiratory tract
hat can lead to aesthetic and functional prejudices. This
athology is rarely encountered in our ENT departments. Its
arly diagnosis is difﬁcult to establish and long-term treat-
ent is necessary. We report our experience management
f this pathology about 14 cases.
aterial and method
his retrospective study was conducted in the ENT and
ead and neck surgery departments in Treichville, Cocody,
opougon and Bouaké from January 1980 to December
008. All the patients treated for rhinoscleroma with com-
lete medical records (clinical examination, histological
onﬁrmation and treatment) were included in the study.
he non-included patients had incomplete medical records.
hus, we retained 14 complete medical records out of 97 650
onsultations over this period of time that is 0.01% of the
atients.
From 2000 onwards, Medical treatment was antibio-
herapy associated with corticoids: streptomycin (1 g/d) or
hiophenicol (1 g/d) between 1980 and 1999 associated with
etamethasone (1mg/g per day) and ciproﬂoxacin/250mg
ne tablet twice daily) surgical treatment was required
n cases of obstructive granuloma and/or sequelae (unaes-
hetic deformities of the nasal pyramid).
esults
n 28 years, 14 cases of rhinoscleroma were studied in the
NT departments of the four university hospitals in the coun-
ry (Table 1) among which nine cases (64.3%) between 1980
nd 1990. The study included nine male and ﬁve female
atients aged from 16 to 81. Mean age was 33.4. The popula-
ion included nine natives of Côte d’Ivoire and ﬁve foreigners
mong whom two natives of Burkina Faso, two Malians and
ne Guinean. Among the natives of Côte d’Ivoire, ﬁve were
riginally from the north of the country. Patients’ monthly
ncome was below guaranteed minimum income (GMI).
The delay in consultation varied between 1 month and 8
ears with an average of 2 years.
The patients consulted for nasal tumefaction (11 cases),
ermanent nasal obstruction (seven cases), endobuccal
umefaction (one case), dysphonia (three cases), mouth
reathing (three cases). These signs were associated in some
atients.
In 11 cases, the disease which ﬁrst involved the nasal
eptum spread to the pharynx (six cases), the larynx (threeK.V. N’gattia et al.
cases among which one where the nasal signs had appeared
a long time after the laryngeal signs), trachea (one case)
and to oral cavity (one case).
Physical examination evidenced a morphological alte-
ration of the nose: ﬂattened nose and radix with an aspect
of saddle nose (ﬁve cases), bumpy, pinched nose or broad
based nose (ﬁve cases), upper lip invasion (one case). Pal-
pation showed ligneous hardness of nasal ala in six cases.
In anterior rhinoscopy, the external nasal valve was imper-
meable (seven cases) with partial nasal obstruction in four
cases with plaques of inﬂamed tissue, nodules or sclero-
sis. In three cases, rhinoscopic examination evidenced a
thickening of the nasal mucosa with dry (two cases) or oo-
zing (one case) granulomatous-crusted secretions. Posterior
rhinoscopy demonstrated hypertrophy of the torus tubarius
with subtotal choanae obstruction in three cases. Examina-
tion of oral cavity and nasopharynx revealed right endolabial
granulations (one case) on the uvula (four cases), the pil-
lars of soft palate and palatine tonsils (two cases), the
right hemipalate (one case) and the larynx (three cases
among which two in the glottic region and one in the supra
and subglottic region). The diagnosis of rhinoscleroma was
established after the histological examination of biopsy sam-
ples showing Mikulicz cells (13 cases) and Russel bodies (one
case).
Evaluation of extension of the disease with air sinus
radiography (Waters’ view) revealed an opacity of at least
one sinus in nine cases. On posterior-anterior and lateral
views, a tracheal and laryngeal intraluminal opacity sug-
gested spreading of scleroma to trachea (one case). Nasal
and paranasal sinus CT Scan realized in three cases, evi-
denced a bulky expanding ﬁrm soft process in the nasal fossa
(three cases) with erosion and harmonious deformity of the
medial wall of the right and left maxillary sinuses causing
bilateral collapse of the maxillary sinus due to the tumor
mass effect (one case) (Fig. 1).Figure 1 Computed tomography of paranasal sinuses eviden-
cing nasal fossa tumor (rhinoscleroma) with bilateral collapse
of maxillary sinuses.
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the lesions; thiophenicol in one 81-year-old patient pre-
senting with sensorineural hearing loss. As early as 2000,
ciproﬂoxacine was used in three patients. Treatment dura-
tion was from 6 months to 1 year. Surgical management
completed medical treatment in two cases. In the ﬁrst case,
we performed the removal of residual scar tissue lesions of
the upper lip, desobstruction of nasal fossa and calibrating
with tubes after nasal septum plasty with bone graft taken
from a rib in order to lift up the nasal dorsum. Six-month
follow-up was satisfactory; then, the patient was lost to
follow-up. Removal of nasal ﬁbrosis with nasal fossa cali-
brating was realized in the second case. The patient was
reviewed 2 years after surgery and there was no recurrence.
Comments
Rhinoscleroma endemic regions are well-known: Tropical
Africa, the Maghreb, South East Asia, Mexico, Central and
South America, Eastern and Central Europe [1—2]. Migra-
tion of population currently causes more and more sporadic
cases in regions spared before then by this disease [3—4].
Mean age of occurrence is between 15 and 35 years [5]
as in our study: 33.4 years. Rhinoscleroma is rare in Côte
d’Ivoire: 14 cases in 28 years that is an average of one case
every 2 years. It is important to note that we observe less
and less cases in our departments (nine cases between 1980
and 1990, three cases from 1991 to 2000 and two cases
from 2001 to December 2008). The majority of our patients
were natives of the northern part of the country bordered by
endemic countries such as Burkina Faso [3]; the patients who
are not originally from Côte d’Ivoire are natives of Burkina
Faso, Mali and Guinea. Socioeconomic level of the patients
is low (monthly income below GMI). Predisposing factors are
malnutrition, poor hygiene and crowded living conditions
[1]. Rhinoscleroma is the ‘‘pathology of poverty’’ [3].
Pathology evolution is divided into four stages: catarrhal
rhinitis, atrophic granulomatous rhinitis, inﬁltrative rhinitis
and sclerotic rhinitis [1]. Most of these changes contribut-
ing to the chronicity of rhinoscleroma occurs in the sube-
pithelium tissue during proliferative phase of the disease.
These critical changes include factors leading to histiocyte
transformation into Mikulicz cells, the inability of these
cells to uniformly destroy Klebsiella, their rupture liberating
viable Klebsiella and the intrinsic resistance of the pathogen
microbe [6]. Rhinoscleroma evolution is often insidious and
the patients ask for medical advice only at obstructive gra-
nulomatous stage with nasal obstruction. Delay in diagnosis
and treatment promoted the local regional propagation of
rhinoscleroma in 11 cases. Nasal localization is predominant
in our series as in the literature [2,3,6] but the affection
can spread to the entire bronchopulmonary tree and to the
bronchi [1,8]. After the main site of infection (nasal fossa),
rhinoscleroma can involve the nasopharynx (18—43%), the
larynx (15—40%), the trachea (12%) and the bronchi (from 2
to 7%) [7].
The clinical presentation is non-speciﬁc but any granulo-
matous rhinitis in this context must evoke the possibility
of rhinoscleroma with oriented histological examination
[9]. Histopathological examination is looking for Mikulicz’s
cells that are pathognomonic for klebsiella rhinoscleroma-
tis (examination of smears, nasal secretions, pathological
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issues. . .). Bacillus is isolated in 98% of the cases by granu-
ation tissue biopsy and, in 60% of the cases by smears from
esions [1]. Bacteriological study with culture for antibio-
herapy was realized in several series [8,10] and only 50 to
0% of the cultures are positive for klebsiella rhinosclero-
atis [2]. The conﬁrmation in our series was made by the
istopathological examination. Spread and repercussion of
hinoscleroma on paranasal sinuses and osteocartilaginous
keleton will be at best demonstrated by CT-Scan and/or MRI
r at least by Waters view [7,11,12]. Initial exploration with
omography, ﬂexible ﬁber-optics and/or endoscopy must
ook for other localizations as well (especially laryngeal and
horacic) often unnoticed [13,14].
Differential clinical diagnosis at early stage is common
hinitis. At tumoral stage diagnoses of leprosy, tertiary
yphilis, cutaneous tuberculosis, sarcoidosis and wegener
ranulomatosis must be ruled out; when scar forma-
ion process occurs, destructive mycosis, mucocutaneous
eishmaniasis on scar tissues and ozena must be evoked
1,3]. Histopathological diagnosis of rhinoscleroma must
e distinguished from the diagnosis of cutaneous lep-
osy, syphilis, tuberculosis, mucocutaneous leishmaniasis,
aracoccidioidomycosis, rhinosporidiosis and wegener gran-
lomatosis [1]. For Abalkhail et al., histologic differential
iagnosis of rhinoscleroma at proliferative stage includes
utaneous leprosy, Malakoplakia, tumors with granuloma-
ous cells and metastatic cells of renal carcinoma [15].
Medical treatment must eradicate the germ in focus, sta-
ilize or partially reduce the lesions and avoid functional
r aesthetic complications. It was based on streptomycin,
ifampicin, sulfamides and clofazimine [1]. Fluoroquinolone
fﬁcacy was demonstrated in this therapeutical manage-
ent [11,16,17]. This could account for the signiﬁcant
ecreasing number of cases of rhinoscleroma encountered
n our consultations over the years. These ﬂuoroquinolones
ere successfully administered in three of our patients.
urgery combined with antibiotic therapy consisted in
epermeabilization of nasal fossa associated with either sep-
oplasty or rhinoseptoplasty according to the case. These
rocedures ensured the improvement of the aesthetic and
unctional comfort in these patients. In cases with pala-
ine localization, uvulopalatopharyngoplasty could relieve
he nasopharyngeal symptoms [18]. Treatment that requires
ong duration of antibiotic therapy makes the patients’
ollow-up often difﬁcult. The majority of our patients was
ost-to-follow-up sometimes at the onset of stabilization of
he lesions.
In the series of Ouoba et al., out of 51 patients with
hinoscleroma, only 13 were came back to consultation 5
ears after treatment [3]. These authors report two cases
f relapse [3].
onclusion
n Côte d’Ivoire, rhinoscleroma has become more and more
ncommon in our consultations. Efﬁcacy of ﬂuoroquinolones
n the treatment of this disease as well as their frequent use
ertainly accounts for this phenomenon. Its clinical polymor-
hism makes its diagnosis difﬁcult to establish. Diagnosis
s often delayed and made at tumoral stage, then granulo-
atosis and even nasal fossa carcinoma must also be evoked.
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